News

Back Publications

Publication: Pharmacokinetics, Safety, & Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain

Publication: Pharmacokinetics, Safety, & Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain

This phase I open-label study, published in the Pain and Therapy journal examined pharmacokinetics, safety, and tolerability of escalating doses of a novel combination cannabinoid medication (1:1 tetrahydrocannabinol [THC]/cannabidiol [CBD]) in patients with chronic non-cancer pain (CNCP) on high dose opioid analgesia.

2021_11_30_Bonomo PK of MC in CNCP and high dose omedd PK safety and tolerability 2022

Call 08 6559 2800Contact